Fetal neural grafts for Huntington's disease: A prospective view
暂无分享,去创建一个
[1] O. Isacson,et al. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence , 2004, Experimental Brain Research.
[2] M. Levivier,et al. Striatal implants protect the host striatum against quinolinic acid toxicity , 2004, Experimental Brain Research.
[3] A. Björklund,et al. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease , 2004, Experimental Brain Research.
[4] Blair R. Leavitt,et al. Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.
[5] P. Bartolomeo,et al. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD , 2001, Neurology.
[6] A. Björklund,et al. First step towards cell therapy for Huntington's disease , 2000, The Lancet.
[7] Anne-Catherine Bachoud-Lévi,et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation , 2000, The Lancet.
[8] T. Deacon,et al. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Remy,et al. Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease , 2000, Experimental Neurology.
[10] P. Remy,et al. MRI-Stereotactical Approach for Neural Grafting in Basal Ganglia Disorders , 1998, Experimental Neurology.
[11] D. Riche,et al. Maturation of Fetal Human Neural Xenografts in the Adult Rat Brain , 1997, Experimental Neurology.
[12] E. Grasbon-Frodl,et al. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease , 1996, Neuroscience.
[13] M. Levivier,et al. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum , 1995, Neuroscience.
[14] M. Peschanski,et al. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease , 1995, Neuroscience.
[15] M. Peschanski,et al. Effects of target deprivation on the morphology and survival of adult dorsal column nuclei neurons , 1995, The Journal of comparative neurology.
[16] S. Juliano,et al. Long-term delayed vascularization of human neural transplants to the rat brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[17] Y. Samson,et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. , 1994, Brain : a journal of neurology.
[18] D. Sax,et al. Factors associated with slow progression in Huntington's disease. , 1991, Archives of neurology.
[19] A. Björklund,et al. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum—III. Efferent projecting graft neurons and their relation to host afferents within the grafts , 1989, Neuroscience.
[20] S. Juliano,et al. Somatic activation of thalamic neurons transplanted into lesioned somatosensory thalamus , 1989, Brain Research.
[21] A. Björklund,et al. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum—I. Subcortical afferents , 1988, Neuroscience.
[22] M. Peschanski,et al. Fetal homotypic transplant in the excitotoxically neuron‐depleted thalamus: Light microscopy , 1988, The Journal of comparative neurology.
[23] A. Björklund,et al. Graft-induced behavioral recovery in an animal model of Huntington disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.